Open access · OA
via OpenAlex
P207 Senolytic effects of Telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells
Shyreen Hassibi, James B. Baker, L Daly, Y Yamamoto, R Kyle, Kazuhiro Ito
Thorax · 2023
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Senolytics
Cell culture / in vitro
Human
Abstract
Background COPD is characterized by pulmonary inflammation and accelerated lung aging, where elevated number of senescent cells are observed. Senescent cells may prevent lung repair and drive chronic lung inflammation. Telaglenastat, a non-competitive glutaminase inhibitor, is recently reported as a potential senolytic agent which removes senescent cells (Johmura et al., Science, 2021). Aim Investigate the senolytic effects of Talaglenastat on airway epithelial cells. Methods Immortalised bronchial epithelial cell line, BEAS-2B cells, were treated with known senescence(definition) inducer etoposide either once or twice (3 days apart). 10 days post-treatment, cellular senescence was characterised by high levels of p21WAF1/CIP1 and p16INK4A expression (western blotting) and Senescence-Associated-b-Galactosidase (SA-β-gal) positive staining (Senescence detection kit, Abcam). Senescent cells were treated with Talaglenastat (0.4 µg/ml) or Dasatinib (200 nM) and Quercetin (50 µM) (D+Q) for 72 hours and changes in senescence markers detected. In addition, human induced pluripotent stem cells (iPSCs)-derived alveolar epithelial cells cultured under the air-liquid interface (ALI) condition (HiLung Inc, Japan), were treated with etoposide to induce senescence, prior to Talaglenastat treatment. Results Talaglenastat treatment showed reduction of SA-β-gal staining in double etoposide treated BEAS-2B (approx. 33% reduction compared to etoposide treated cells, p<0.05, n=4). Senolytic cocktail, Dasatinib and Quercetin reduced senescent cell number, but not% SA-β-gal staining. In addition, Talaglenastat showed a concentration dependent reduction of p21WAF1/CIP1 and p16INK4A expression with IC90 values of 0.725 and 0.284, respectively, in BEAS-2B cells with etoposide single treatment. Etoposide single and double hit also induced cellular senescence in iPSc ALI alveolar epithelium, characterised by an increase in p21WAF1/CIP1 and p16INK4A expression, and therapeutic treatment of Talaglenastat (0.057µg/ml) reduced the senescence marker expression. Conclusion Telaglenastat displayed senolytic activities in etoposide treated senescent BEAS-2B cells and ALI cultured iPSC alveolar epithelium. This profile suggests that Telaglenastat offers the potential therapeutic treatment for patients with COPD. Please refer to page A292 for declarations of interest related to this abstract.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1136/thorax-2023-btsabstracts.357
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Hassibi, S., Baker, J.B., Daly, L., Yamamoto, Y., Kyle, R., & Ito, K. (2023). P207 Senolytic effects of Telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells. <em>Thorax</em>. https://doi.org/10.1136/thorax-2023-btsabstracts.357
Vancouver
Hassibi S, Baker JB, Daly L, Yamamoto Y, Kyle R, Ito K. P207 Senolytic effects of Telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells. Thorax. 2023. doi:10.1136/thorax-2023-btsabstracts.357.
BibTeX
@article{shyreen2023PSenol,
title = {P207 Senolytic effects of Telaglenastat, a glutaminase inhibitor, on senescent airway epithelial cells},
author = {Shyreen Hassibi and James B. Baker and L Daly and Y Yamamoto and R Kyle and Kazuhiro Ito},
journal = {Thorax},
year = {2023},
doi = {10.1136/thorax-2023-btsabstracts.357},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Thorax 2023
Open access · OA
P206 Identification of novel senolytic candidates for the treatment of chronic respiratory diseases with accelerating aging
PLoS ONE 2021
Open access · CC-BY
Senotherapeutic-like effect of Silybum marianum flower extract revealed on human skin cells
European Respiratory Journal 2023
Citation only
The senolytic effect of Dasatinib and Quercetin on cellular senescence in COPD in vitro and in vivo models
Frontiers in Medicine 2025
Open access · CC-BY
Senolytic therapy reduces inflammation in epithelial cells from COPD patients and in smoke-exposure mice
Journal of Visualized Experiments 2017
Preprint · OA
Techniques to Induce and Quantify Cellular Senescence
Journal of Visualized Experiments 2017
Citation only